Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Jevtana Approved In The US

August 4, 2010 7:55 am | News | Comments

Sanofi-aventis announced that Jevtana Injection is now available in the United States for patients with metastatic hormone-refractory prostate cancer previously treated with a docetaxel-based treatment regimen.


FDA Gives Orphan Drug Designation to XOMA 052

August 4, 2010 7:52 am | News | Comments

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Food and Drug Administration has designated XOMA 052, an antibody to interleukin-1 beta, an orphan drug for the treatment of Behcet's disease.


Iron Balancing Proteins Discovered

August 4, 2010 7:41 am | News | Comments

Most organisms need iron to survive, but too much iron is toxic, and can cause fatal organ failure. The same is true inside cells, where iron balance must also be maintained.


New Breakthrough In Controlled Drug Release

August 4, 2010 7:38 am | News | Comments

New research provides a theoretical model that compares the transport characteristics of straight- and branched-chain polymers in smooth channels as well as in channels whose walls interact with the polymer, work that could aid in delivering drugs at a controlled rate in the body.


Scientists Find Way to Destroy Brain Cancer Cell

August 4, 2010 7:34 am | News | Comments

A major breakthrough in how to target and destroy the most malignant and aggressive brain cancer cells has been made by researchers at Wake Forest University Baptist Medical Center.


Researchers Find Bridge Between Inate And Adaptive Immune Systems

August 4, 2010 7:31 am | News | Comments

Researchers have found a new mechanism that explains how certain immune cells are activated to create protective antibodies against infections or pathological antibodies such as those present in autoimmune diseases like lupus and rheumatoid arthritis.


Genzyme-Isis Drug Cut Patient's Cholesterol

August 4, 2010 7:08 am | News | Comments

Genzyme Corp. and Isis Pharmaceuticals Inc. said their cholesterol drug candidate mipomersen proved effective at significantly cutting patients' bad cholesterol levels in two late-stage studies.


More Health Care Reform Provisions Around The Corner

August 4, 2010 7:06 am | by Tom Murphy | News | Comments

Health care reform hits another milestone next month, with new provisions that include a coverage expansion for young adults and restrictions on an insurer's ability to impose annual coverage limits or to reject children with pre-existing medical conditions.


Sanofi Stock Skittish Over Genzyme Rumors

August 4, 2010 6:58 am | News | Comments

The stock has fallen nearly 6 percent over the last month since speculation emerged that Sanofi-Aventis was eyeing Cambridge, Mass.-based Genzyme, maker of the Cerezyme and Fabrazyme drugs to treat genetic diseases.


Pfizer Profits Unexpectedly Rise 9%

August 4, 2010 6:37 am | by Linda A. Johnson | News | Comments

Pfizer Inc. reported a 9 percent rise in second-quarter profit, trouncing Wall Street expectations as revenue jumped 58 percent due to favorable currency rates and its mega-acquisition of fellow drugmaker Wyeth last October.


FDA Stepping Up Oversight of Medical Devices

August 4, 2010 6:33 am | by Matthew Perrone | News | Comments

Makers of X-ray machines, drug pumps and other medical devices would have to submit more safety information to win federal approval under a proposal designed to tighten regulation of thousands of products reviewed each year.


Genotyping Array

August 3, 2010 8:37 am | Product Releases | Comments

Affymetrix, Inc. announced that it will develop and commercialize the Axiom Chinese myDesign Genotyping Array, the first product that provides maximum power for genome-wide association studies specifically on Chinese populations.


Multiplexing Instrument

August 3, 2010 8:32 am | Product Releases | Comments

Luminex Corporation announced the global launch of MAGPIX, an analytical instrument that is capable of performing up to 50 tests on a single sample and providing nearly 5,000 data points in under an hour.


Telormedix Studying TMX-201 For Malaria

August 3, 2010 8:26 am | News | Comments

Telormedix announced the start of a collaboration with the Swiss Tropical and Public Health Institute (Swiss TPH) on a pilot study using Telormedix’s adjuvant, TMX-201, in connection with immunization for malaria and Buruli ulcer.


Cornerstone Licenses Patents to Targacept

August 3, 2010 8:20 am | News | Comments

Cornerstone Therapeutics Inc. announced that it has licensed to Targacept, Inc. the worldwide rights to its nicotinic-receptor based patents and library of preclinical compounds that target the alpha-7 or other nicotinic receptors.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.